Cargando…
Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis
PURPOSE: This meta-analysis compared the long-term (12 months or 24 months) efficacy and safety of intravitreal aflibercept injection (IAI) for diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR). METHODS: We selected 16 randomized controlled trials (RCTs) performed after 2015...
Autores principales: | Xie, Xiao, Lian, Chao, Zhang, Zhiping, Feng, Meng, Wang, Wenqi, Yuan, Xiaomeng, Shi, Yanmei, Liu, Tingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227619/ https://www.ncbi.nlm.nih.gov/pubmed/37260449 http://dx.doi.org/10.3389/fendo.2023.1144422 |
Ejemplares similares
-
The association between different hypoglycemic regimens and postoperative diabetic macular edema after vitrectomy in the Japanese patients with proliferative diabetic retinopathy
por: Lei, Chunyan, et al.
Publicado: (2022) -
The correlation between peripheral complete blood count parameters and diabetic macular edema in proliferative diabetic retinopathy patients: a cross-sectional study
por: Lei, Chunyan, et al.
Publicado: (2023) -
The role of aflibercept in the management of diabetic macular edema
por: Chang, Andrew A, et al.
Publicado: (2015) -
The clinical utility of aflibercept for diabetic macular edema
por: Stewart, Michael W
Publicado: (2015) -
Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy
por: Graham, Patricia S., et al.
Publicado: (2018)